-
Genetically determined telomere length and risk for haematologic diseases: results from large prospective cohorts and Mendelian Randomization analysis Blood Cancer J. (IF 12.8) Pub Date : 2024-03-18 Yang Li, Jia Chen, Ting Sun, Yunfei Chen, Rongfeng Fu, Xiaofan Liu, Feng Xue, Wei Liu, Mankai Ju, Xinyue Dai, Huan Dong, Huiyuan Li, Wentian Wang, Ying Chi, Lei Zhang
-
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry Blood Cancer J. (IF 12.8) Pub Date : 2024-03-18 H. V. Giles, M. T. Drayson, B. Kishore, C. Pawlyn, M. Kaiser, G. Cook, R. de Tute, R. G. Owen, D. Cairns, T. Menzies, F. E. Davies, G. J. Morgan, G. Pratt, G. H. Jackson
-
Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century Blood Cancer J. (IF 12.8) Pub Date : 2024-03-14 Kari Hemminki, Frantisek Zitricky, Asta Försti, Mika Kontro, Bjorn T. Gjertsen, Marianne Tang Severinsen, Gunnar Juliusson
-
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation Blood Cancer J. (IF 12.8) Pub Date : 2024-03-15 Olaf Penack, Mouad Abouqateb, Christophe Peczynski, William Boreland, Zafer Gülbas, Tobias Gedde-Dahl, Cristina Castilla-Llorente, Nicolaus Kröger, Mathias Eder, Alessandro Rambaldi, Francesca Bonifazi, Igor Wolfgang Blau, Matthias Stelljes, Peter Dreger, Ivan Moiseev, Hélène Schoemans, Christian Koenecke, Zinaida Peric
-
In vivo expression of anti-CD19/CD3 BiTE by liver-targeted AAV for the treatment of B cell malignancies Blood Cancer J. (IF 12.8) Pub Date : 2024-03-15 Zhiqiang Song, Ping Liu, Dongliang Zhang, Tao Wang, Wenqin Yue, Yuke Geng, Na Liu, Yang Wang, Jianmin Yang
-
Large differencies in age-specific survival in multiple myeloma in the nordic countries Blood Cancer J. (IF 12.8) Pub Date : 2024-03-11 Kari Hemminki, Frantisek Zitricky, Asta Försti, Raija Silvennoinen, Annette Vangsted, Markus Hansson
-
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma Blood Cancer J. (IF 12.8) Pub Date : 2024-03-07 Kylie Keijzer, Janneke W. de Boer, Jaap A. van Doesum, Walter Noordzij, Gerwin A. Huls, Lisanne V. van Dijk, Tom van Meerten, Anne G. H. Niezink
-
Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy Blood Cancer J. (IF 12.8) Pub Date : 2024-03-06 Yujie Liu, Yuqing Tu, Jinyan Xiao, Yifan Shen, Biqi Zhou, Qiannan Yang, Lei Yu, Lijuan Qi, Jia Chen, Tianhui Liu, Depei Wu, Yang Xu
-
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing Blood Cancer J. (IF 12.8) Pub Date : 2024-03-06 Jian-rong Li, Shahram Arsang-Jang, Yan Cheng, Fumou Sun, Anita D’Souza, Binod Dhakal, Parameswaran Hari, Quillan Huang, Paul Auer, Yong Li, Raul Urrutia, Fenghuang Zhan, John D. Shaughnessy, Siegfried Janz, Jing Dong, Chao Cheng
-
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study Blood Cancer J. (IF 12.8) Pub Date : 2024-03-05 Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina Schinke, Anita D’Souza, Meera Mohan
-
Regulation of HOX gene expression in AML Blood Cancer J. (IF 12.8) Pub Date : 2024-03-07 Irum Khan, Mohammed A. Amin, Elizabeth A. Eklund, Andrei L. Gartel
-
Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia Blood Cancer J. (IF 12.8) Pub Date : 2024-03-06 Liangliang Wu, Limin Liu, Xin Zhao, Ming Zhou, Andie Fu, Yuping Zhang, Wenrui Yang, Xiaowei Chen, Wenjian Mo, Caixia Wang, Yumiao Li, Shilin Xu, Shiyi Pan, Ruiqing Zhou, Fankai Meng, Fengkui Zhang, Depei Wu, Shunqing Wang
-
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study Blood Cancer J. (IF 12.8) Pub Date : 2024-03-05 Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al-Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits van Rhee, Anita D’Souza, Aniko Szabo, Carolina Schinke, Rajshekhar Chakraborty
-
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry Blood Cancer J. (IF 12.8) Pub Date : 2024-02-29 Pedro Horna, Matthew J. Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng, Zulaikha Akbar, F. Tudor Ilca, Gregory E. Otteson, Jansen N. Seheult, Janosch Ortmann, Min Shi, Paul M. Maciocia, Marco Herling, Martin A. Pule, Horatiu Olteanu
-
Update on the management of relapsed/refractory chronic lymphocytic leukemia Blood Cancer J. (IF 12.8) Pub Date : 2024-02-21 Rory Bennett, John F. Seymour
-
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND) Blood Cancer J. (IF 12.8) Pub Date : 2024-02-20 Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M. Shallis, Sacchi de Camargo Correia Guilherme, Aaron D. Goldberg, Antoine N. Saliba, Anand Patel, Jan P. Bewersdorf, Adam S. DuVall, Danielle Bradshaw, Yasmin Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M. Zeidan, Vamsi Kota, Mark R. Litzow
-
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial Blood Cancer J. (IF 12.8) Pub Date : 2024-02-19 Eolia Brissot, Myriam Labopin, Helene Labussière, Gaelle Fossard, Patrice Chevallier, Thierry Guillaume, Ibrahim Yakoub-Agha, Micha Srour, Claude-Eric Bulabois, Anne Huynh, Sylvain Chantepie, Anne-Lise Menard, Marie-Therese Rubio, Patrice Ceballos, Rémy Dulery, Sabine Furst, Florent Malard, Didier Blaise, Mohamad Mohty
-
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems Blood Cancer J. (IF 12.8) Pub Date : 2024-02-14 Wancheng Guo, Yihao Zhan, David Mery, Eric R. Siegel, Fumou Sun, Yan Cheng, Timothy Cody Ashby, Zijun Zhang, Clyde Bailey, Daisy V. Alapat, Hongling Peng, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina Schinke, Maurizio Zangari, Frits van Rhee, Guido Tricot, John D. Shaughnessy, Fenghuang Zhan
-
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma Blood Cancer J. (IF 12.8) Pub Date : 2024-02-13 Danmei Xu, Findlay Bewicke-Copley, Karina Close, Jessica Okosun, Robert Peter Gale, Jane Apperley, David M. Weinstock, Hans-Guido Wendel, Jude Fitzgibbon
-
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms—a Danish longitudinal study Blood Cancer J. (IF 12.8) Pub Date : 2024-02-09 Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T. Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Hasselbalch, Christina Ellervik
-
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas Blood Cancer J. (IF 12.8) Pub Date : 2024-02-08 Asaad Trabolsi, Artavazd Arumov, Jonathan H. Schatz
-
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity Blood Cancer J. (IF 12.8) Pub Date : 2024-02-06 Ioannis V. Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios-Athanasios Dimopoulos, Ourania Tsitsilonis, Efstathios Kastritis
-
Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM) Blood Cancer J. (IF 12.8) Pub Date : 2024-02-05 Christopher P. Mill, Warren C. Fiskus, Courtney D. DiNardo, Patrick Reville, John A. Davis, Christine E. Birdwell, Kaberi Das, Hanxi Hou, Koichi Takahashi, Lauren Flores, Xinjia Ruan, Xiaoping Su, Sanam Loghavi, Joseph D. Khoury, Kapil N. Bhalla
-
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review Blood Cancer J. (IF 12.8) Pub Date : 2024-02-02 Paula Rodriguez-Otero, Niels W. C. J. van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Philippe Moreau, Nizar Bahlis, Ajai Chari
-
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia Blood Cancer J. (IF 12.8) Pub Date : 2024-01-25 Thomas Roberts, Grace Uwenedi, Rachel Bruton, Graham McIlroy, Sarah Damery, Panagiota Sylla, Nicola Logan, Sam Scott, May Lau, Ahmed Elzaidi, Siobhan Plass, Soumyajit Mallick, Katie Spencer, Christine Stephens, Christopher Bentley, Guy Pratt, Jianmin Zuo, Shankara Paneesha, Brian Willett, Paul Moss, Helen Parry
-
Genetics and pathologic landscape of lineage switch of acute leukemia during therapy Blood Cancer J. (IF 12.8) Pub Date : 2024-01-25 Ting Zhou, Choladda V. Curry, Mahsa Khanlari, Min Shi, Wei Cui, Deniz Peker, Weina Chen, Endi Wang, Juehua Gao, Qi Shen, Wei Xie, Fatima Z. Jelloul, Rebecca L. King, Ji Yuan, Xiaoqiong Wang, Chen Zhao, Ifeyinwa E. Obiorah, Elizabeth L. Courville, Eric Nomura, Sindhu Cherian, Mina L. Xu, W. Richard Burack, Hong-xing Liu, Elias J. Jabbour, Koichi Takahashi, Wei Wang, Sa A. Wang, Joseph D. Khoury, L.
-
Genome-wide CRISPR/Cas9 screen identifies regulators of BCMA expression on multiple myeloma cells Blood Cancer J. (IF 12.8) Pub Date : 2024-01-25 Ram Ajore, Jenny Mattsson, Maroulio Pertesi, Ludvig Ekdahl, Zain Ali, Markus Hansson, Björn Nilsson
-
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review Blood Cancer J. (IF 12.8) Pub Date : 2024-01-25 Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira Mian, Luciano J. Costa, Douglas Sborov, Ghulam Rehman Mohyuddin
-
Bi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives Blood Cancer J. (IF 12.8) Pub Date : 2024-01-25 Iman Abou Dalle, Remy Dulery, Nour Moukalled, Laure Ricard, Nicolas Stocker, Jean El-Cheikh, Mohamad Mohty, Ali Bazarbachi
-
Prediction models for essential thrombocythemia from two longitudinal studies involving 2000 patients Blood Cancer J. (IF 12.8) Pub Date : 2024-01-23 Tiziano Barbui, Alessandra Carobbio
-
Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression? Blood Cancer J. (IF 12.8) Pub Date : 2024-01-23 Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Adriana Carolei, Margherita Massa, Robert Peter Gale, Vittorio Rosti
-
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations Blood Cancer J. (IF 12.8) Pub Date : 2024-01-23 Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor-Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
-
PICH deficiency limits the progression of MYC-induced B-cell lymphoma Blood Cancer J. (IF 12.8) Pub Date : 2024-01-23 María Castejón-Griñán, Eliene Albers, Lucía Simón-Carrasco, Paula Aguilera, Mauro Sbroggio, David Pladevall-Morera, Andreas Ingham, Ernest Lim, Alba Guillen-Benitez, Elena Pietrini, Michael Lisby, Ian D. Hickson, Andres J. Lopez-Contreras
-
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study Blood Cancer J. (IF 12.8) Pub Date : 2024-01-18 Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
-
One thousand patients with essential thrombocythemia: the Mayo Clinic experience Blood Cancer J. (IF 12.8) Pub Date : 2024-01-18 Naseema Gangat, Omer Karrar, Aref Al-Kali, Kebede H. Begna, Michelle A. Elliott, Alexandra P. Wolanskyj-Spinner, Animesh Pardanani, Curtis A. Hanson, Rhett P. Ketterling, Ayalew Tefferi
-
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience Blood Cancer J. (IF 12.8) Pub Date : 2024-01-18 Giuseppe G. Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro M. Vannucchi, Paola Guglielmelli
-
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders Blood Cancer J. (IF 12.8) Pub Date : 2024-01-18 Gianpietro Semenzato, Giulia Calabretto, Antonella Teramo, Vanessa Rebecca Gasparini, Elisa Rampazzo, Gregorio Barilà, Renato Zambello
-
Mode of progression in smoldering multiple myeloma: a study of 406 patients Blood Cancer J. (IF 12.8) Pub Date : 2024-01-17 Nadine H. Abdallah, Arjun Lakshman, Shaji K. Kumar, Joselle Cook, Moritz Binder, Prashant Kapoor, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, David Dingli, Yi Lin, Taxiarchis Kourelis, Rahma Warsame, Leif Bergsagel, S. Vincent Rajkumar
-
MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study Blood Cancer J. (IF 12.8) Pub Date : 2024-01-17 Yang Cao, Wenxuan Huo, Jiayu Huang, Yang Yang, Yu Wang, Yingjun Chang, Luxiang Wang, Zilu Zhang, Chuanhe Jiang, Xiaoxia Hu, Xiaodong Mo
-
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk Blood Cancer J. (IF 12.8) Pub Date : 2024-01-15 Ashwin Kishtagari, M. A. Wasay Khan, Yajing Li, Caitlyn Vlasschaert, Naimisha Marneni, Alexander J. Silver, Kelly von Beck, Travis Spaulding, Shannon Stockton, Christina Snider, Andrew Sochacki, Dixon Dorand, Taralynn M. Mack, P. Brent Ferrell, Yaomin Xu, Cosmin A. Bejan, Michael R. Savona, Alexander G. Bick
-
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience Blood Cancer J. (IF 12.8) Pub Date : 2024-01-10 Oren Pasvolsky, Sassine Ghanem, Denái R. Milton, Mikael Rauf, Mark R. Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Guilin Tang, Yosra Aljawai, Hina N. Khan, Partow Kebriaei, Hans C. Lee, Krina K. Patel, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J. Shpall, Richard E. Champlin, Muzaffar H. Qazilbash
-
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms Blood Cancer J. (IF 12.8) Pub Date : 2024-01-04 Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
-
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands Blood Cancer J. (IF 12.8) Pub Date : 2024-01-04 Elise R. A. Pennings, Müjde Durmaz, Otto Visser, Eduardus F. M. Posthuma, Djamila E. Issa, Martine E. D. Chamuleau, Pieternella J. Lugtenburg, Marie José Kersten, Avinash G. Dinmohamed
-
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma Blood Cancer J. (IF 12.8) Pub Date : 2024-01-04 A. V. de Jonge, J. A. A. Bult, D. F. E. Karssing, M. Nijland, M. E. D. Chamuleau, M. Brink
-
Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M Blood Cancer J. (IF 12.8) Pub Date : 2023-12-21 David Fandrei, Tony Huynh, Marie Sébert, Lorea Aguinaga, Valeria Bisio, Rathana Kim, Emmanuelle Clappier, Marion Espéli, Karl Balabanian, Hélène Moins-Teisserenc, Antoine Toubert, Nicolas Dulphy, Pierre Fenaux, Lionel Adès, Lin-Pierre Zhao
-
Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse? Blood Cancer J. (IF 12.8) Pub Date : 2023-12-21 Carlotta Giupponi, Diego Bertoli, Erika Borlenghi, Chiara Cattaneo, Tatiana Zollner, Lorenzo Masina, Samuele Bagnasco, Elisa Cerqui, Francesca Federico, Chiara Pagani, Silvana Archetti, Duilio Brugnoni, Giuseppe Rossi, Alessandra Tucci
-
Sociodemographic associations with uptake of novel therapies for acute myeloid leukemia Blood Cancer J. (IF 12.8) Pub Date : 2023-12-21 Andrew Hantel, Colin Cernik, Hajime Uno, Thomas P. Walsh, Gregory S. Calip, Daniel J. DeAngelo, Christopher S. Lathan, Gregory A. Abel
-
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience Blood Cancer J. (IF 12.8) Pub Date : 2023-12-20 Sara A. Scott, Ellen M. Marin, Kathryn T. Maples, Nisha S. Joseph, Craig C. Hofmeister, Vikas A. Gupta, Madhav V. Dhodapkar, Jonathan L. Kaufman, Sagar Lonial, Ajay K. Nooka
-
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis Blood Cancer J. (IF 12.8) Pub Date : 2023-12-19 Marie-France Gagnon, Alan R. Penheiter, Faye Harris, Dorsay Sadeghian, Sarah H. Johnson, Giannoula Karagouga, Alexa McCune, Cinthya Zepeda-Mendoza, Patricia T. Greipp, Xinjie Xu, Rhett P. Ketterling, Ellen D. McPhail, Rebecca L. King, Jess F. Peterson, George Vasmatzis, Linda B. Baughn
-
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia Blood Cancer J. (IF 12.8) Pub Date : 2023-12-18 Rong Fan, Hatice Satilmis, Niels Vandewalle, Emma Verheye, Elke De Bruyne, Eline Menu, Nathan De Beule, Ann De Becker, Gamze Ates, Ann Massie, Tessa Kerre, Marie Törngren, Helena Eriksson, Karin Vanderkerken, Karine Breckpot, Ken Maes, Kim De Veirman
-
Addressing the disparities: the approach to the African American patient with multiple myeloma Blood Cancer J. (IF 12.8) Pub Date : 2023-12-18 Manisha Bhutani, Brandon J. Blue, Craig Cole, Ashraf Z. Badros, Saad Z. Usmani, Ajay K. Nooka, Leon Bernal-Mizrachi, Joseph Mikhael
There are significant disparities with regards to incidence, timely diagnosis, access to treatment, clinical trial participation and health care utilization that negatively impact outcomes for African American patients with multiple myeloma. Health care providers have a role in ameliorating these disparities with thoughtful consideration of historical, sociocultural, individual and disease characteristics
-
The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients Blood Cancer J. (IF 12.8) Pub Date : 2023-12-15 Tiziano Barbui, Alessandra Carobbio, Juergen Thiele, Naseema Gangat, Elisa Rumi, Alessandro Rambaldi, Alessandro M. Vannucchi, Ayalew Tefferi
-
The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma Blood Cancer J. (IF 12.8) Pub Date : 2023-12-14 Jinrong Zhao, Chong Wei, Shuqing Wang, Yan Zhang, Wei Wang, Danqing Zhao, Zi Wang, Zhipeng Zhou, Jing Bai, Wei Zhang, Daobin Zhou
-
Muscle and fat composition in patients with newly diagnosed multiple myeloma Blood Cancer J. (IF 12.8) Pub Date : 2023-12-12 Nadine H. Abdallah, Hiroki Nagayama, Naoki Takahashi, Wilson Gonsalves, Amie Fonder, Angela Dispenzieri, David Dingli, Francis K. Buadi, Martha Q. Lacy, Miriam Hobbs, Morie A. Gertz, Moritz Binder, Prashant Kapoor, Rahma Warsame, Suzanne R. Hayman, Taxiarchis Kourelis, Yi L. Hwa, Yi Lin, Robert A. Kyle, S. Vincent Rajkumar, Stephen M. Broski, Shaji K. Kumar
-
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma Blood Cancer J. (IF 12.8) Pub Date : 2023-12-11 Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, Moritz Binder, Francis K. Buadi, Joselle Cook, David Dingli, Angela Dispenzieri, Amie L. Fonder, Morie A. Gertz, Wilson Gonsalves, Suzanne R. Hayman, Miriam A. Hobbs, Yi L. Hwa, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar
-
Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study Blood Cancer J. (IF 12.8) Pub Date : 2023-12-11 Oihane Pérez-Escurza, Juan Flores-Montero, Jón Þórir Óskarsson, Luzalba Sanoja-Flores, Julio del Pozo, Quentin Lecrevisse, Silvia Martín, Elín Ruth Reed, Guðlaug Katrín Hákonardóttir, Stephen Harding, Sigrún Þorsteinsdóttir, Sæmundur Rögnvaldsson, Thorvardur Jon Love, Brian Durie, Sigurður Yngvi Kristinsson, Alberto Orfao
-
BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma Blood Cancer J. (IF 12.8) Pub Date : 2023-12-11 Debasmita Dutta, Jiye Liu, Kenneth Wen, Keiji Kurata, Mariateresa Fulciniti, Annamaria Gulla, Teru Hideshima, Kenneth C. Anderson
-
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure Blood Cancer J. (IF 12.8) Pub Date : 2023-12-10 Miriam Mozaffari Jovein, Gabriele Ihorst, Jesús Duque-Afonso, Ralph Wäsch, Hartmut Bertz, Claudia Wehr, Justus Duyster, Robert Zeiser, Jürgen Finke, Florian Scherer
-
Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database Blood Cancer J. (IF 12.8) Pub Date : 2023-12-08 A. Visram, A. De La Torre, D. White, J. Su, E. Masih-Khan, M. Chu, V. Jimenez-Zepeda, A. McCurdy, R. LeBlanc, K. Song, H. Mian, M. Louzada, M. Sebag, D. Bergstrom, J. Stakiw, A. Reiman, R. Kotb, M. Aslam, C. Venner, R. Kaedbey, E. Gul, D. Reece
-
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma Blood Cancer J. (IF 12.8) Pub Date : 2023-12-07 Amit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder, Vithal Madhira, Timothy Bergquist, Yu Raymond Shao, Feifan Liu, Qianqian Song, Jing Su, Shaji Kumar, Benjamin A. Bates, Noha Sharafeldin, Umit Topaloglu